[1] Hamid, Y. A., Kadhim, K. A., & Rahmah, A. M. (2019). Effect of melatonin as adjuvant on some of the suggested screening tools and markers of sleep disordered breathing (sleep apnea) in a specimen of Iraqi controlled acromegalic patients. Journal of Pharmaceutical Sciences and Research, 11(4), 1278-1286.
[2] Li, Y., Ma, J., Yao, K., Su, W., Tan, B., Wu, X., Huang, X., Li, T., Yin, Y., Tosini, G., & Yin, J. (2020). Circadian rhythms and obesity: Timekeeping governs lipid metabolism. Journal of pineal research, 69(3), e12682. https://doi.org/10.1111/jpi.12682.
[3] Song, Y. M., & Chen, M. D. (2009). Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice. Acta biologica Hungarica, 60(4), 399–407.
https://doi.org/10.1556/ABiol.60.2009.4.6
[4] Mayoral, L. P. C., Andrade, G. M., Mayoral, E. P. C., Huerta, T. H., Canseco, S. P., Canales, F. J. R., ... & Perez-Campos, E. (2020). Obesity subtypes, related biomarkers & heterogeneity. The Indian journal of medical research, 151(1), 11.
[5] Guan, Q., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2021). Mechanisms of melatonin in obesity: a review. International journal of molecular sciences, 23(1), 218.
[6] Szewczyk‐Golec, K., Woźniak, A., & Reiter, R. J. (2015). Inter‐relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity. Journal of pineal research, 59(3), 277-291.
[7] Cooper, C. B., Neufeld, E. V., Dolezal, B. A., & Martin, J. L. (2018). Sleep deprivation and obesity in adults: a brief narrative review. BMJ open sport & exercise medicine, 4(1), e000392. https://doi.org/10.1136/bmjsem-2018-000392
[8] Ding, C., Lim, L. L., Xu, L., & Kong, A. P. S. (2018). Sleep and Obesity. Journal of obesity & metabolic syndrome, 27(1), 4–24. https://doi.org/10.7570/jomes.2018.27.1.4
[9] St-Onge M. P. (2017). Sleep-obesity relation: underlying mechanisms and consequences for treatment. Obesity reviews : an official journal of the International Association for the Study of Obesity, 18 Suppl 1, 34–39. https://doi.org/10.1111/obr.12499
[10] Lin, J., Jiang, Y., Wang, G., Meng, M., Zhu, Q., Mei, H., Liu, S., & Jiang, F. (2020). Associations of short sleep duration with appetite-regulating hormones and adipokines: A systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity, 21(11), e13051. https://doi.org/10.1111/obr.13051
[11] Frank, S., Gonzalez, K., Lee-Ang, L., Young, M. C., Tamez, M., & Mattei, J. (2017). Diet and Sleep Physiology: Public Health and Clinical Implications. Frontiers in neurology, 8, 393. https://doi.org/10.3389/fneur.2017.00393
[12] Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505), 425–432. https://doi.org/10.1038/372425a0
[13] Friedman, J. M. (2019). Leptin and the endocrine control of energy balance. Nature Metabolism, 1(8), 754-764.
[14] Ertosun, M. G., Kocak, G., & Ozes, O. N. (2019). The regulation of circadian clock by tumor necrosis factor alpha. Cytokine & growth factor reviews, 46, 10-16.
[15] Suriagandhi, V., & Nachiappan, V. (2022). Protective Effects of Melatonin against Obesity‐Induced by Leptin Resistance. Behavioural brain research, 417, 113598.
[16] Izquierdo, A. G., Crujeiras, A. B., Casanueva, F. F., & Carreira, M. C. (2019). Leptin, obesity, and leptin resistance: where are we 25 years later?. Nutrients, 11(11), 2704.
[17] Ahima R. S. (2008). Revisiting leptin's role in obesity and weight loss. The Journal of clinical investigation, 118(7), 2380–2383. https://doi.org/10.1172/JCI36284
[18] Zieba, D. A., Biernat, W., & Barć, J. (2020). Roles of leptin and resistin in metabolism, reproduction, and leptin resistance. Domestic animal endocrinology, 73, 106472.
[19] Inagaki-Ohara, K. (2019). Gastric leptin and tumorigenesis: beyond obesity. International Journal of Molecular Sciences, 20(11), 2622.
[20] Reid, I. R., Baldock, P. A., & Cornish, J. (2018). Effects of Leptin on the Skeleton. Endocrine reviews, 39(6), 938–959. https://doi.org/10.1210/er.2017-00226
[21] Huang L, Li C. Leptin: a multifunctional hormone. Cell Res. 2000 Jun;10(2):81-92. doi: 10.1038/sj.cr.7290038. PMID: 10896170.
[22] Farr, O. M., Gavrieli, A., & Mantzoros, C. S. (2015). Leptin applications in 2015: what have we learned about leptin and obesity?. Current opinion in endocrinology, diabetes, and obesity, 22(5), 353–359. https://doi.org/10.1097/MED.0000000000000184
[23] Kelesidis, T., Kelesidis, I., Chou, S., & Mantzoros, C. S. (2010). Narrative review: the role of leptin in human physiology: emerging clinical applications. Annals of internal medicine, 152(2), 93–100. https://doi.org/10.7326/0003-4819-152-2-201001190-00008
[24] Dixit M, Poudel SB, Yakar S. Effects of GH/IGF axis on bone and cartilage. Mol Cell Endocrinol. 2021 Jan 1;519:111052. doi: 10.1016/j.mce.2020.111052. Epub 2020 Oct 14. PMID: 33068640; PMCID: PMC7736189.
[25] Reinehr T, Lindberg A, Koltowska-Häggström M, Ranke M. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data. Clin Endocrinol (Oxf). 2014 Nov;81(5):721-6. doi: 10.1111/cen.12464. Epub 2014 May 26. PMID: 24750131.
[26] Guevara-Aguirre J, Guevara A, Palacios I, Pérez M, Prócel P, Terán E. GH and GHR signaling in human disease. Growth Horm IGF Res. 2018 Feb;38:34-38. doi: 10.1016/j.ghir.2017.12.006. Epub 2017 Dec 12. PMID: 29395968.
[27] Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018 Jan;6(1):45-53. doi: 10.1016/j.sxmr.2017.02.004. Epub 2017 Apr 8. PMID: 28400207; PMCID: PMC5632578.
[28] Kopchick JJ, Basu R, Berryman DE, Jorgensen JOL, Johannsson G, Puri V. Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer. Nat Rev Endocrinol. 2022 Sep;18(9):558-573. doi: 10.1038/s41574-022-00702-6. Epub 2022 Jun 24. PMID: 35750929; PMCID: PMC9703363.
[29] Bogusławska A, Korbonits M. Genetics of Acromegaly and Gigantism. J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377. PMID: 33805450; PMCID: PMC8036715.
[30] Laron Z, Werner H. Laron syndrome - A historical perspective. Rev Endocr Metab Disord. 2021 Mar;22(1):31-41. doi: 10.1007/s11154-020-09595-0. Epub 2020 Sep 22. PMID: 32964395.
[31] Ma, W., Wu, H., Li, G., Yan, L., Wang, L., Zhao, M., et al (2022). Melatonin promotes the growth and development of lambs by increasing growth hormone and testosterone, targeting on apoptosis signaling pathway and intestinal microflora. Frontiers in endocrinology, 13, 966120. https://doi.org/10.3389/fendo.2022.966120
[32] Bolamperti, S., Signo, M., Spinello, A., Moro, G., Fraschini, G., Guidobono, F., Rubinacci, A., & Villa, I. (2018). GH prevents adipogenic differentiation of mesenchymal stromal stem cells derived from human trabecular bone via canonical Wnt signaling. Bone, 112, 136–144. https://doi.org/10.1016/j.bone.2018.04.014
[33] ÇAKIR, A., Sehzade, S., KOÇ, C., & KAHVECİ, N. (2023). Melatonin Treatment Affects Leptin and Nesfatin-1 Levels but not Orexin-A Levels in REM Sleep Deprived Rats. Kafkas Universitesi Veteriner Fakultesi Dergisi, 23(5).
[34] Mendoza-Herrera, K., Florio, A. A., Moore, M., Marrero, A., Tamez, M., Bhupathiraju, S. N., & Mattei, J. (2021). The Leptin System and Diet: A Mini Review of the Current Evidence. Frontiers in endocrinology, 12, 749050. https://doi.org/10.3389/fendo.2021.749050
[35] Buonfiglio, D., Parthimos, R., Dantas, R., Cerqueira Silva, R., Gomes, G., Andrade-Silva, J., et al. (2018). Melatonin Absence Leads to LongTerm Leptin Resistance and Overweight in Rats. Frontiers in endocrinology, 9, 122. https://doi.org/10.3389/fendo.2018.00122
[36] Valcavi, R., Dieguez, C., Azzarito, C., Edwards, C. A., Dotti, C., Page, M. D., et al. (1987). Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects. Clinical endocrinology, 26(4), 453–458. https://doi.org/10.1111/j.1365-2265.1987.tb00802.x
[37] Selthofer-Relatić, K., Radić, R., Stupin, A., Šišljagić, V., Bošnjak, I., Bulj, N., et al. (2018). Leptin/adiponectin ratio in overweight patients - gender differences. Diabetes & vascular disease research, 15(3), 260–262. https://doi.org/10.1177/1479164117752491
[38] Delpino, F. M., & Figueiredo, L. M. (2021). Melatonin supplementation and anthropometric indicators of obesity: A systematic review and meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.), 91-92, 111399. https://doi.org/10.1016/j.nut.2021.111399
[39] de Farias, T. D. S. M., Cruz, M. M., de Sa, R. C. D. C., Severi, I., Perugini, J., Senzacqua, M., et al. (2019). Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice. Frontiers in endocrinology, 10, 750. https://doi.org/10.3389/fendo.2019.00750
[40] Hernández Morante, J. J., Díaz Soler, I., Muñoz, J. S. G., Sánchez, H. P., Barberá Ortega, M. D. C., Martínez, C. M., & Morillas Ruiz, J. M. (2020). Moderate Weight Loss Modifies Leptin and Ghrelin Synthesis Rhythms but Not the Subjective Sensations of Appetite in Obesity Patients. Nutrients, 12(4), 916. https://doi.org/10.3390/nu12040916
[41] Furigo, I. C., Teixeira, P. D. S., de Souza, G. O., Couto, G. C. L., Romero, G. G., Perelló, M., Frazão, R., Elias, L. L., Metzger, M., List, E. O., Kopchick, J. J., & Donato, J., Jr (2019). Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons. Nature communications, 10(1), 662.
https://doi.org/10.1038/s41467019-08607-1
[42] AL-Salami, R. M., AL-Jewari, M. M., & Abduljabbar, H. A. (2013). The effects of growth hormone replacement therapy on insulin, lipid profile and calcium in children with growth hormone deficiency. Journal of the Faculty of Medicine Baghdad, 55(1), 91-96.